DENTSPLY SIRONA Inc. (XRAY) Position Raised by Parkwood LLC

Parkwood LLC boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 63.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,498 shares of the medical instruments supplier’s stock after purchasing an additional 38,298 shares during the quarter. Parkwood LLC’s holdings in DENTSPLY SIRONA were worth $5,891,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in DENTSPLY SIRONA by 2.5% in the second quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock valued at $1,473,688,000 after purchasing an additional 562,993 shares in the last quarter. Principal Financial Group Inc. raised its stake in DENTSPLY SIRONA by 22.3% in the second quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after purchasing an additional 1,181,547 shares in the last quarter. Veritas Asset Management LLP raised its stake in DENTSPLY SIRONA by 2.6% in the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after purchasing an additional 157,616 shares in the last quarter. Epoch Investment Partners Inc. raised its stake in DENTSPLY SIRONA by 3.5% in the second quarter. Epoch Investment Partners Inc. now owns 3,686,004 shares of the medical instruments supplier’s stock valued at $239,001,000 after purchasing an additional 123,668 shares in the last quarter. Finally, Parnassus Investments CA raised its stake in DENTSPLY SIRONA by 62.7% in the third quarter. Parnassus Investments CA now owns 2,115,000 shares of the medical instruments supplier’s stock valued at $126,498,000 after purchasing an additional 815,000 shares in the last quarter. 93.71% of the stock is currently owned by institutional investors and hedge funds.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded down $1.19 during trading on Monday, hitting $63.61. 1,271,953 shares of the stock traded hands, compared to its average volume of 1,992,630. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. DENTSPLY SIRONA Inc. has a 1 year low of $52.53 and a 1 year high of $66.00. The company has a market capitalization of $14,871.72, a PE ratio of 25.82, a price-to-earnings-growth ratio of 2.66 and a beta of 1.27.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $978.99 million. During the same quarter last year, the business earned $0.66 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. analysts forecast that DENTSPLY SIRONA Inc. will post 2.67 earnings per share for the current year.

A number of brokerages recently weighed in on XRAY. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 target price on shares of DENTSPLY SIRONA in a research note on Monday. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a research report on Monday. Stifel Nicolaus reiterated a “buy” rating and set a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. UBS AG reiterated a “neutral” rating and set a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, Robert W. Baird set a $63.00 price target on shares of DENTSPLY SIRONA and gave the company a “buy” rating in a research report on Thursday, October 19th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $66.60.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/11/06/dentsply-sirona-inc-xray-position-raised-by-parkwood-llc.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

What are top analysts saying about DENTSPLY SIRONA Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DENTSPLY SIRONA Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit